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Abstract
Influenza A viruses are a severe threat worldwide, causing large epidemics that kill thousands every year. Prevention of
influenza infection is complicated by continuous viral antigenic changes. Newer anti-influenza agents include MEK/ERK and
protein kinase C inhibitors; however, the downstream effectors of these pathways have not been determined. In this study,
we identified a common mechanism for the inhibitory effects of a significant group of anti-influenza agents. Our studies
showed that influenza infection activates a series of signaling pathways that converge to induce myosin light chain (MLC)
phosphorylation and remodeling of the actin cytoskeleton. Inhibiting MLC phosphorylation by blocking RhoA/Rho kinase,
phospholipase C/protein kinase C, and HRas/Raf/MEK/ERK pathways with the use of genetic or chemical manipulation leads
to the inhibition of influenza proliferation. In contrast, the induction of MLC phosphorylation enhances influenza
proliferation, as does activation of the HRas/Raf/MEK/ERK signaling pathway. This effect is attenuated by inhibiting MLC
phosphorylation. Additionally, in intracellular trafficking studies, we found that the nuclear export of influenza
ribonucleoprotein depends on MLC phosphorylation. Our studies provide evidence that modulation of MLC
phosphorylation is an underlying mechanism for the inhibitory effects of many anti-influenza compounds.
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Introduction
The emergence of highly contagious influenza A virus strains,
such as the new H1N1 swine influenza, is a serious threat to
global human health. Two classes of anti-influenza agents are
currently available for use during an influenza pandemic-M2
channel blockers and neurominidase inhibitors. However,
continuous antigenic changes enhance the probability of
increased resistance to these drugs. Moreover, a high frequency
of resistance in clinical isolates in the United States has led to the
conclusion that M2 inhibitors should not be used for the
prevention or treatment of influenza until susceptibility to these
drugs has been re-established among circulating influenza A
isolates [1]. Because of their relatively small genomic coding
capacity, influenza A viruses extensively manipulate and exploit
host cell functions to support viral replication. Therefore,
targeting cellular proteins required for influenza replication is a
valuable alternative for preventing and treating infections. This
approach is advantageous in that the development of drug
resistance is unlikely and the drugs target common pathways used
by human, avian, and other influenza viruses. However, this
strategy requires an understanding of the intracellular pathways
that the influenza virus uses to replicate. The actin cytoskeleton
plays a critical role in viral replication [2]. Contraction and
relaxation of the actin cytoskeleton are primarily regulated by
phosphorylation and dephosphorylation of the regulatory subunit
of myosin light chain (MLC) [3]. Phosphorylation of MLC is
controlled by a balance of activation and deactivation of myosin
light chain kinase (MLCK) and myosin light chain phosphatase
(MLCP) [4]. The classic pathway through which contracting
stimuli induce MLC phosphorylation is by coupling their
receptors to heterotrimeric G proteins, resulting in the activation
of phospholipase C (PLC) beta isoforms, the formation of inositol-
1, 4, 5-trisphosphate, and an increased concentration of free
cytosolic Ca
+2. The complex of Ca
+2 and calmodulin then
activates MLCK, leading to increased MLC phosphorylation
(Fig. 1). The Ca
+2-independent regulation of actin-myosin
contraction occurs through the inhibition of MLCP and involves
other biochemical cascades, including the monomeric GTP-
binding protein RhoA, protein kinase C (PKC), and the Ras/
Raf/MEK/ERK signaling cascade [4,5,6]. Activation of RhoA
leads to the stimulation of Rho-kinase, which, in turn,
phosphorylates the regulatory myosin-binding subunit of MLCP,
resulting in the inhibition of MLCP. Another pathway for
inhibiting MLCP involves the activation of PKC, which leads to
phosphorylation and activation of CPI-17. Furthermore, activa-
tion of the HRas/Raf/MEK/ERK signaling cascade also leads to
activation of MLCK and inactivation of MLCP [6,7,8]. Nitric
oxide (NO) increases cGMP concentration by activating guanylyl
cyclase, which, in turn, activates protein kinase G (PKG). PKG
inhibits MLC phosphorylation by reducing intracellular Ca
+2
levels and activating MLCP [3,9].
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21444Influenza-induced activation of Raf/MEK/ERK, PKC, and
PLC has been reported [10,11,12]. Influenza infection also leads
to an increase in intracellular calcium levels and actin polymer-
ization [13]. These studies suggest that the signal transductions
that are involved in MLC phosphorylation and actin cytoskeleton
remodeling are activated after influenza infection. Furthermore, it
is well documented that the inhibition of Raf/MEK/ERK and
PKC signaling pathways leads to inhibition of influenza prolifer-
ation [12,14]. In addition to MEK/ERK and PKC inhibitors,
calcium channel blockers, calmodulin inhibitors, NO donors, and
agents that restrict actin polymerization have anti-influenza effects
[15,16,17,18]. However, the underlying molecular mechanisms for
these anti-influenza properties have not been determined. The
common thread among these agents is the inhibition of MLC
phosphorylation and alteration in actin contractile function (Fig. 1).
Thus, in the present study, we tested the hypothesis that inhibition
of MLC phosphorylation leads to inhibition influenza virus
replication.
Materials and Methods
Reagents
Phospho-specific and nonphospho-specific antibodies against
ERK1/2, nonmuscle myosin II, and fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse secondary and anti-FITC–
HRP antibodies were obtained from Abcam. Monoclonal phospho-
antibody against MLC and specific antibody against MLC were
purchased from Sigma-Aldrich. Phospho-specific and nonphospho-
specific antibodies against MLCK and the catalytic subunit of
MLCP (MYPT) were obtained from Santa Cruz Biotechnology.
Recombinant TNF-a, PKC activator (Phorbol-12-myristate-13-
acetate, PMA), RhoA inhibitor (C3 exoenzyme), Rho kinase
inhibitors (Y-27632, Fasudil), MLCK inhibitor (ML-7), MEK
inhibitors (U0126, PD-98059), protein kinase C inhibitor (bisindo-
lylmaleimide I), phospholipase C inhibitor (U73122), Raf-1 kinase
inhibitor (GW 5074), calmodulin antagonist (trifluoperazine
dimaleate), intracellular Ca
2+ chelator (BAPTA-AM), calcium
channel blocker (verapamil), MLCP inhibitor (calyculin A), sodium
nitroprosside, 8-Br-cGMP, and cytochalasin D were purchased
from Calbiochem (San Diego, CA). LFL was purchased from EY
Laboratories, Inc. Tyramide signal amplification kits (TSA,
Fluorescein) were obtained from PerkinElmer. Anti-influenza
monoclonal antibody against nucleoprotein was purchased from
Chemicon International, Inc. Premade recombinant adenoviruses
of ERK2 (DN), Ras V12 (CA), Ras N17 (DN), Raf-1 (DN), RhoA
N19 (DN), RhoA L63 (CA), null control, GFP, and ViraDuctin
adenovirustransductionreagentswerepurchasedfromCellBiolabs.
A mutant construct for DN MLCK was a generous gift from Dr.
Yasuo Mori (National Institute for Physiological Sciences, Okazaki,
Aichi,Japan).Smallinterfering RNA(siRNA)andTaqMan primers
and probes for MYPT, Rho kinase1/2, Ga12/13, and Gaq11 were
purchased from Applied Biosystems.
Cells
HUVECs and MDCK cells were purchased from American
Type Culture Collection. NHBE cells were purchased from Lonza
(Rockland, ME). MDCK cells were grown in Dulbelcco’s
Modified Eagle Medium (DMEM)+10% FBS. HUVECs and
NHBE were grown in Endothelial Cell Growth Medium-2 (EGM-
2, Lonza) and Bronchial Epithelil Cell Growth Medium (BEGM,
Lonza), respectively. HUVECs and NHBE cells from fewer than 4
generations were used for all experiments.
Cell viability assay
The effects of chemicals on the viability of MDCK cells and
HUVECs were determined by using the 3-[4, 5-dimethylthiazol-2-
yl]-2, 5-diphenyl tetrazoliumbromide (MTT) assay, as previously
described [19].
Viral infection
Influenza virus A/Hong Kong/2/68; H3N2 [A/HK (H3N2)]
was used as the primary influenza virus strain in all experiments.
When grown to 90% confluency, HUVECs or MDCK cells were
washed twice with PBS to remove residual fetal bovine serum
(FBS) and were infected with virus at an MOI of 10 or 0.01 to
allow single-cycle (8–10 h after infection) or multicycle (24 h after
Figure 1. Pathway model used in this study. Signal transduction pathways involved in myosin light chain phosphorylation. MLC, myosin light
chain; PKG, protein kinase G.
doi:10.1371/journal.pone.0021444.g001
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free DMEM for 60 minutes at 37uC to inoculate the cells
(adsorption phase). Cells were then washed with PBS and cultured
in DMEM+2% FBS and tolylsulfonyl phenylalanyl chloromethyl
ketone (TPCK) trypsin (4 mg/ml, Worthington Biochemicals,
Tryp-MEM ), either with or without drug treatment, for 8 to
24 h (postinfection phase).
Extracellular virus yield reduction assay
These assays were performed in 24-well plates containing
confluent MDCK monolayers (4 times for each experiment). The
drugs were added to cells in 24-well plates, and the plates were
incubated for 0.5 to 8 h at 37uC. The cells were then inoculated
with virus, first for 1 h, and then again after washing for 24 h at
37uC in DMEM+2% FBS and TPCK trypsin. The medium was
removed and centrifuged at 3,2006 g for 5 min to remove the
floating cells and then used for ribonucleic acid extraction and
quantification of virus by using qPCR.
qPCR assay
TaqMan real-time PCR was used to quantify the presence of
virus after infection with influenza virus, as described [19]. The
agreement between conventional techniques used for influenza
replication (eg, plaque assay and TCID 50%) with qPCR
technique has been established [19]. We used qPCR because it
was faster than conventional techniques (8 h vs 3–4 days). The
primer and probe sequences for detection of influenza A were
previously optimized [20]. The primers (forward) 59 AAG ACC
AAT CCT GTC ACC TCT GA 39 and (reverse) 59CAA AGC
GTC TAC GCT GCA GTC C 39 amplify a 104-base pair
fragment in the M1 gene of influenza A. The influenza A–specific
probe FAM (6-carboxyfluorescein)-59 TTT GTG TTC ACG
CTC ACC GT 39 TAMRA (6-carboxytetramethylrhodamine)
annealed to part of the sequence amplified by the 2 primers.
Immunofluorescence staining of influenza virus
Cells were fixed in 4% paraformaldehyde for 15 min at 4uC,
washed with PBS, and permeabilized for 5 min with 0.1% Triton-
X-100. Viral nucleoprotein (NP) protein was detected by using
mouse monoclonal antibody (Chemicon International, Inc.). The
secondary antibody used was FITC-conjugated goat anti-mouse
IgG. Tyramide signal amplification system was used in conjunc-
tion with anti-influenza antibody. After quenching the remaining
horseradish peroxidase (HRP) activity with 1% H2O2,1mg/ml
anti-FITC–HRP (for 30 min) and FITC-Tyramide (Molecular
Probes) were used to reveal FITC–anti-influenza staining. Hoechst
33342 (0.5 mg/ml for 5 minutes) was used as a nuclear counter-
stain. Fluorescent images were acquired by MicroSuite FIVE
software (Olympus Soft Imaging Solutions) with an Olympus
BX61 motorized microscope (Olympus America).
Western blot assay
Cell lysates were separated on sodium dodecyl sulfate (SDS)-
polyacrylamide gels, transferred onto nitrocellulose membranes,
and stained with primary antibodies, as indicated in figure legends.
Secondary antibodies were conjugated to HRP (Sigma). Mem-
branes were developed by use of an enhanced chemiluminescence
system (Cell Signaling Technology, Inc.).
Transduction of adenovirus and transfection of siRNA
and plasmids
All reagents and kits, including transduction reagents, adeno-
virus purification kit, and adenovirus titration kit were purchased
from Cell Biolabs, Inc. After purification, the titration of each
recombinant adenovirus was determined by an enzyme-linked
immunosorbent assay (ELISA) titrating kit. Null control recombi-
nant adenovirus (empty vector) served as a control for other
recombinant adenovirus used. HUVECs, NHBE or MDCK cells
were seeded into 6-well plates for 24 h until they reached 80%
confluency. According to the manufacturer’s protocol, adenovirus
was transduced into cells by using ViraDuctin (Cell Biolabs, Inc.).
HUVECs or MDCK cells were infected with adenoviral vectors
with an MOI of 100 plaque-forming units per cell in the presence
of ViraDuctin. After incubation with viral particles for 48 h, the
cells were assessed for the expression of the transduced genes.
Plasmids and siRNA were transfected into cells by using
Lipofectamine 2000 (Invitrogen). Scrambled siRNA (a non-
targeting siRNA pool) or pcDNA3.1 empty vector were transfect-
ed as the controls. Cells were collected 24 h after transfection with
siRNA or plasmids.
RhoA, Rho kinase, and PKC activity assays
RhoA activity was determined by using a RhoA G-LISA
Activation Assay kit according to the manufacturer’s protocol
(Cytoskeleton, Inc.). This assay is based on the principle that a
Rho-GTP-binding protein is linked to the 96-well plates. The
active GTP-bound Rho in the cell lysates binds to the wells, while
the inactive GDP-bound Rho is removed during the washing
steps. The bound active RhoA is detected with a RhoA specific
antibody and quantified by absorbance. The degree of RhoA
activation is determined by comparing readings from the infected
cell lysates versus the non-infected cell lysates [21]. A commer-
cially available kit was used to measure Rho kinase activity
according to the manufacturer’s instruction (CycLex Co., Ltd.;
MBL International Corporation). In brief, the supernatants of
lysed cells were measured for protein concentrations and justified
to the same protein concentration and then added (10 ml/well)
into 96-well plates precoated with a substrate corresponding to the
C terminus of the recombinant myosin-binding subunit of myosin
phosphate (MSB), which contains a threonine residue that may be
phosphorylated by Rho kinase. Subsequently, 90 ml of kinase
reaction buffer was added to the kinase reaction, incubated for
60 min at room temperature, washed five times in washing buffer
provided in the kit, and incubated with 100 ml of horseradish
peroxidase-conjugated monoclonal antiphospho-specific MSB
antibody. The colored products were developed by incubating
with 100 ml of the horseradish peroxidase substrate tetramethyl-
benzidine at room temperature for 10 min. The colored products
were quantified by spectrophotometry at 450 nm [22]. Total PKC
activity in cells was measured by using the PKC Assay kit from
Calbiochem (San Diego, CA). The protocol established by the
company was used as described [23]. A total of 108 ml of reaction
was placed in each well of a polyvinyl plate and preincubated at
25uC for 5 min. Samples (12 ml), including PKC standards (the
active PKC protein) were added to each well and mixed. Each
sample was run in duplicate. A total of 100 ml of each sample in
reaction mixture was transferred to pseudosubstrate- coated wells
with a multichannel pipetter. After incubation at 25uC for 15 min,
the reaction mixture was removed from the plate, and the plate
was washed five times with PBS. Biotinylated Ab 2B9 (100 ml)
directed to the phosphorylated pseudosubstrate was added to each
well and incubated at 25uC for 60 min. Peroxidase-conjugated
streptavidin (100 ml) was then added to each well and incubated
for another 60 min. The wash was repeated after incubation and
100 ml of substrate solution (o-phenylenediamine) was added to
each well. Stop solution (100 ml) was added after 3–5 min and the
96-well plate was read at 492 nm in a microplate reader.
Myosin Light Chain and Influenza
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Cells were loaded with 4 mg of fluo-3 acetoxymethyl (AM) and
10 mg of Fura-Red AM (Molecular Probes, Inc.) as described [24].
Flow cytometry analysis was performed at 488 nm excitation, and
the fluorescence of fluo-3 was collected at 520 nm, and Fura-Red
emission was collected at 640 nm. An in situ calibration assay for
calcium measurements in HUVECs was performed as described
[25]. The fluo-3/Fura-Red ratio versus calcium concentration was
plotted and used to calculate [Ca
2+]i in each sample as described
[25].
Actin assays
Actin polymerization was measured by quantifying the ratio of
F actin to G actin by using a G actin/F actin assay kit (BK037;
Cytoskeleton, Inc.). Actin fibers were stained by using rhodamine
phalloidin from the F-actin visualization Biochem Kit (BK005;
Cytoskeleton, Inc).
Results
Influenza A virus infects and replicates in HUVECs
Although the Madin Darby canine kidney (MDCK) cell line is
most commonly used for influenza studies, we and others have
shown that the influenza virus infects and replicates in human
umbilical vein endothelial cells (HUVECs) [26,27]. However,
influenza replicates to a lesser extent in HUVECs than in MDCK
cells [27]. Because the MDCK cell line is not a human cell line,
antibody reagents and siRNAs are not readily available. Thus, we
used MDCK cells mainly for studying the effects of inhibitors or
stimuli on influenza replication, and we used HUVECs for signal
transduction and siRNA experiments. As shown below the results
obtained from HUVECs and MDCK cells were similar for both
influenza-induced signal transductions and influenza intracellular
trafficking and proliferation.
Optimization of adenovirus transduction and siRNA and
plasmid transfection
The transduction conditions for the adenovirus recombinants
were optimized by using adenovirus-encoding green fluorescent
protein (GFP). The average transduction rate of HUVECs and
MDCK cells with the recombinant GFP-adenovirus was 80% to
90% (Fig. 2A). To confirm the efficiency of transductions for the
adenovirus recombinants that were used in the study, we tested
either the function of the proteins (eg, pull-down assay for HRas
and RhoA and ELISA activity assay for PKC) or the downstream
effectors of the genes. Transduction of HUVECs with HRas and
Raf led to increase in ERK phosphorylation (Fig. 2B). A FITC-
labeled, double-stranded siRNA (Invitrogen) was used to optimize
the transfection of siRNA into HUVECs and normal human
bronchial epithelial (NHBE). The siRNA for MYPT, Rho
Figure 2. Validation of adenovirus transduction and siRNA and plasmid transfection. (A) The average transduction rate of HUVECs with
the recombinant GFP-adenovirus was 80% to 90%. HUVECs were transduced with GFP adenovirus and after 48 h were assessed for transfection rate.
Hoechst 33342 (0.5 mg/ml for 5 minutes) was used as a nuclear counter-stain. Fluorescent images were acquired by MicroSuite FIVE software
(Olympus Soft Imaging Solutions) with an Olympus BX61 motorized microscope. Bar, 10 mm. (B) Transdution of HUVEC with CA-HRas and CA-Raf
adenoviruses induced ERK phosphorylation. HUVECs were transduced with the indicated adenoviruses and 48 h were used for blotting. (C) Treatment
of HUVECs with siRNA for MYPT, Rho kinase1/2, Ga12/13, and Gaq11 led to reduction in the mRNA expression. HUVECs were transfected with the
indicated si RNA and after 24 h the m RNA leves for each gene were quatified by TaqMan real-time PCR . *P,0.01; N=4 for each experiment. (D)
Overexpression of the DN mutant of MLC kinase in HUVECs led to a 2.5-fold reduction in MLC phosphorylation. HUVECs were transfected with DN
mutant of MLC kinase and 24 h later were used for blotting.
doi:10.1371/journal.pone.0021444.g002
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Biosystems. To confirm the efficiency of siRNA transfection, we
used TaqMan real-time PCR to measure the mRNA expression of
genes of interest. The average siRNA transfection rate was 70%,
and we observed an average 3–4–fold decrease in the mRNA
expression of MYPT, Rho kinase1/2, Ga12/13, and Gaq11 in
cells treated with the respective siRNA (Fig. 2C). The vector
pcDNA3.1/CT-GFP TOPO (Invitrogen) was used to optimize the
transfection of MLCK plasmids into HUVECs and MDCK cells.
The average transfection rate for pcDNA3.1/CT-GFP was 30%
to 40%. Inhibition of MLC kinase in HUVECs by overexpression
of the DN mutant of MLC kinase led to a 2.5-fold reduction in
MLC phosphorylation (Fig. 2D).
Influenza infection induces phosphorylation of MLC
Infection of permissive cells with influenza viruses induces
activation of several intracellular signaling pathways that are then
used by the virus for its own replication [28,29]. Specifically,
influenza infection induces activation of the Raf/MEK/ERK
signaling cascade, which is required for virus replication [12]. The
mechanism by which ERK activation facilitates influenza
replication is unknown; however, direct phosphorylation of a viral
protein by MEK and ERK is not believed to be involved [12].
To facilitate infection, bacterial and viral pathogens induce
remodeling of the actin cytoskeleton in the cytoplasm of host cells.
The effects of ERK activation on phosphorylation of MLCK,
MLC, and cell motility have been demonstrated [6,7]. We sought
to investigate the effects of influenza on signaling pathways
involved in actin cytoskeleton function. Infection of HUVECs with
influenza virus (multiplicity of infection [MOI], 10) increased the
intracellular concentration of calcium, a factor critical for
contraction of the cytoskeleton, and led to phosphorylation of
MLC kinase (Fig. 3, A and B). Thus, we studied possible
alterations in other signaling pathways that are involved in actin
cytoskeleton remodeling, particularly MLC phosphorylation. The
phosphorylation of MLC kinas was accompanied by activation of
PKC, RhoA GTPase, Rho kinase, and the phosphorylation/
inactivation of the myosin-phosphatase targeting (MYPT) subunit
of MLC phosphatase (Fig. 3, C–F). In addition, MLC phosphor-
ylation was simultaneously induced by influenza virus (Fig. 3, G).
The phosphorylation of MLC and the activation of the above-
mentioned signaling pathways followed a biphasic pattern that
Figure 3. Influenza infection increases intracellular calcium, induces phosphorylation of MLCK, MYPT, and MLC, and activates PKC,
RhoA, and Rho kinase. HUVECs were infected with influenza virus (MOI, 10) and were collected at the indicated times points [after infection] for
calcium measurement by using fluo-3/Fura. Red fluorescence ratios (A), blotting for MLCK phosphorylation (B), and measurement of activities of PKC
(C), RhoA (D) and Rho kinase (E). Influenza infection increases MYPT and MLC phosphorylation. HUVECs were infected with influenza virus (MOI, 10)
and after the indicated time were lysed and used for MYPT-P (F) and MLC-P (G) blotting. N=4 for each experiments.
doi:10.1371/journal.pone.0021444.g003
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cycle. Infection of MDCK cells with influenza virus resulted in the
phosphorylation of MLC, MLC kinase, and MLC phosphatase
(data not shown). These studies indicate that influenza infection
leads to phosphorylation of MLC, which correlates with the
activation of MLC kinase and the inactivation of MLC
phosphatase. In addition to ERK activation [12], influenza
infection activates the signaling pathways upstream of MLC
phosphorylation-PKC and RhoA/Rho kinase.
Influenza infection leads to remodeling of the actin
cytoskeleton
Viruses use multiple mechanisms of movement within cells,
ranging from diffusion within the cytosol to active transport along
cytoskeletal filaments. Globular-actin (G-actin) readily polymer-
izes under physiologic conditions to form filamentous-actin (F-
actin) with the concomitant hydrolysis of ATP. To determine the
effect of MLC phosphorylation on the actin cytoskeleton, we
increased MLC phosphorylation by treating HUVECs with
calyculin A (an inhibitor of MLC phosphatase) and then
examined G-actin polymerization. Calyculin A treatment of
HUVECs resulted in the induction of MLC phosphorylation and
G-actin polymerization (Fig. 4, A and B). Infection of HUVECs
with influenza virus also led to an increase (almost two fold) in the
ratio of F actin to G actin and to the formation of actin stress
fibers, as detected by phalloidin staining (Fig. 4, C and D). The
interaction of actin and myosin required the polymerization of
actin and the assembly of myosin thick filaments. Myosin thick
filaments are dynamic cytoskeletal structures that undergo
regulated assembly [30], which depends on phosphorylation of
MLC [31]. Influenza infection of HUVECs increased the
assembly of myosin II, as indicated by immunofluorescence
studies (Fig. 4 E). We found that influenza infection of MDCK
cells also led to an increase in actin fiber formation and the ratio
of F actin to G actin (data not shown). These experiments
indicate that influenza infection leads to remodeling of the actin
cytoskeleton.
Engagement of sialic acid leads to phosphorylation of
ERK and MLC
The viral surface glycoprotein hemagglutinin mediates cellular
adhesion by recognizing and binding to sialic residues on the cell
surface. The accumulation of influenza hemagglutinin on the
surface of infected cells results in the activation of the
Raf\MEK\ERK signaling cascade [32]. To determine if MLC
phosphorylation is mediated by the interaction of hemagglutinin
and sialic acid, we exposed HUVECs to Limax flavus lectin (LFL),
which is a specific ligand for sialic acid. Exposure of HUVECs to
LFL led to phosphorylation of ERK and MLC in a dose-
dependent manner (Fig. 5A, B).
Figure 4. Infection of HUVECs with influenza virus leads to remodeling of actin cytoskeleton. Treatment of HUVECs with calyculin A
induces MLC phosphorylation (A). HUVECs were treated with the indicated concentration of calyculin A for 15 minutes. MLC phosphorylation leads to
an increase in the F-actin to G-actin ratio (B). HUVECs were treated with 500 nM of calyculin A (caly) or DMSO (Con) and, after 15 minutes, were
homogenized in F-actin stabilization buffer and then centrifuged to separate the F-actin [F] from the G-actin [G] pool. The fractions were separated by
SDS-PAGE, and actin was quantified by Western blot. Influenza infection increased actin polymerization, the formation of actin stress fibers, and the
assembly of myosin. HUVECs were infected with influenza (MOI, 10); 8 h later, the F/G ratio was measured (C). Actin fiber formation (D) and assembly
of non-muscle myosin II (E) were assessed by specific staining using fluorescence microscopy. Actin fibers were detected by Texas-red conjugated
phalloidin. Primary antibodies were used to bind myosin II, and FITC-conjugated secondardy antibodies were used for detection. Hoechst 33342 was
used as nuclear counterstain (blue). Bar, 10 mm. *P,0.01. N=4 for each experiments.
doi:10.1371/journal.pone.0021444.g004
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influenza-induced ERK phosphorylation
Signaling via the Ras/Raf/MEK/ERK pathway is commonly
initiated by receptor tyrosine kinases or by G-protein–coupled
receptors [33]. Heterotrimeric G protein a (Ga) is implicated in
Ca
2+ flux, cytoskeletal functions, and activation of Rho family of
GTPases [34]. To understand the role of heterotrimeric G
proteins in influenza-induced ERK phosphorylation, we inhibited
the expression of Ga 12/13 and Gaq/11 by using siRNA-silencing
techniques. Inhibition of Ga 12/13 but not Gaq/11 attenuated
influenza-induced ERK phosphorylation in HUVECs (Fig. 5C).
The inhibition and induction of MLC phosphorylation
inhibits and enhances influenza proliferation,
respectively
Several anti-influenza compounds have been described, including
those that inhibit intracellular calcium, PKC, and Raf/MEK/ERK,
as well as calmodulin antagonists and donors of nitric oxide (NO)
[12,14,15,16,17]. As shown in Fig. 1, the common denominator for
all of these compounds is their involvement in phosphorylation/
dephosphorylation of MLC. Therefore, we tested the hypothesis that
inhibiting MLC phosphorylation by blocking signaling pathways that
regulate MLC phosphorylation prevents the proliferation of the
influenza virus. We found that inhibiting MLC kinase by treating
MDCK cellswith MLC kinase inhibitor (ML-7) or by expressing DN
MLCK prevented influenza proliferation (Fig. 6, A and B). Similar
results were obtained when MDCK cells were treated with a Rho
kinase (fasudil) or a phospholipase C inhibitor (U73122) (Fig. 6, C and
D). To further study this issue, we used real-time polymerase chain
reactionto examinetheeffect ofinhibitingother pathwaysinvolved in
MLC phosphorylation on influenza replication. We found that
influenza proliferation was inhibited in a dose-dependent manner by
treating MDCK cells with the following: BAPTA-AM (an intracel-
lular calcium chelator) or verapamil (a calcium-channel blocker), C3
exoenzyme (inhibits RhoA); trifluoperazin dimaleate (inhibits cal-
modulin);bisindolylmaleimideI(inhibitsPKC);U0126andPD98059
(inhibit MEK/ERK); GW 5074 (inhibits Raf-1); or cytochalasin D
(inhibits actin polymerization) (table 1, data not shown). In addition,
treatment of MDCK cells with an NO donor (sodium nitroprusside)
or an activator of PKG (8-Br-cGMP) inhibited influenza proliferation
(table 1, data not shown).
Next, we tested whether increased MLC phosphorylation also
increased proliferation of influenza virus. Thus, we induced MLC
phosphorylation by treating MDCK cells with an MLC phospha-
tase inhibitor (calyculin A), a PKC activator (PMA), or TNF-a.
Treatment of MDCK cells with either calyculin A, PMA or TNF-
a increased phosphorylation of MLC (Fig. 6 E, data for calyculin
A not shown). Furthermore, addition of these agents to MDCK
cells dose-dependently increased proliferation of the influenza
virus (Fig. 6, F–H). These findings suggest that MLC phosphor-
ylation is critical for influenza proliferation.
It has been well established that inhibition of RhoA GTPase,
calcium/calmodulin and PKC, or increase in NO or cGMP
inhibit stimuli-induced MLC phosphorylation [35,36,37]. How-
ever, for the less-studied inhibitory compounds that we used in the
above-mentioned experiments, we studied their effects on MLC
phosphorylation after influenza infection. Pretreatment of HU-
VECs with Raf-1 inhibitor, GW 5074, phospholipase C inhibitor,
U73122 and MEK/ERK inhibitor, PD98059 attenuated influen-
za-induced MLC phosphorylation (Fig. 6 I). These experiments
indicate that the compounds that inhibited influenza proliferation
have the ability to inhibit MLC phosphorylation. Induction or
inhibition of MLC phosphorylation with all the above-mentioned
agents in HUVECs yielded similar results (data not shown).
Influenza-induced MLC phosphorylation is mediated by
HRas, RhoA, and PKC-activation
To investigate the signaling mechanism underlying the phos-
phorylation of MLC after influenza infection, we sought to examine
thesignalingpathwaysupstreamofMLCphosphorylation.Previous
studies demonstrated that activation of Raf/MEK/ERK is crucial
for proliferation of the influenza virus [12,38,39]. However, it is
believed that ERK activation is not due to the accumulation of viral
RNA[32].TheRaf/MEK/ERKsignalcascade canbeactivatedby
Ras or PKC-a [40,41], the latter of which has been reported to be
the upstream signal that leads to Raf/MEK/ERK activation after
influenza infection [32]. On the other hand, it has been reported
that RhoA activation leads to sequential activation of phospholipase
C-e, PKC-a, and ERK [42]. RhoA activation also promots ERK
phosphorylation by activation of MEKK1 [43,44]. To determine
the roles of HRas, PKC-a, and RhoA in influenza-induced ERK
and MLC phosphorylation, DN mutants of these genes were
overexpressed in HUVECs. We found that influenza-induced ERK
and MLC phosphorylation was attenuated when HRas, PKC-a,o r
RhoA were inhibited by their DN mutants (Fig. 7 A, B). These
findings suggest that influenza-induced MLC phosphorylation is
mediated by HRas, PKC-a, or RhoA signal transduction pathways.
The increase in ERK phosphorylation during the late phase of
the influenza replication cycle has been shown to depend on
accumulation of hemagglutinin on the cell surface of infected cells
[32]. Therefore, it may be argued that the reduction in influenza-
induced ERK phosphorylation in the above-mentioned experi-
ment is due to the inhibitory effects of these pathways in the
proliferation of influenza virus (via other mechanisms) and not due
to their direct effect in influenza-induced ERK phosphorylation.
Thus, we simulated influenza-induced ERK and MLC phosphor-
ylation by using LFL to bind sialic acid. LFL-induced phosphor-
ylation of MLC and ERK was attenuated when HUVECs were
transduced with the DN mutants of HRas, Raf-1, PKC-a, and
Figure 5. Engagement of sialic acid leads to phosphorylation of ERK and MLC. Treatment of HUVECs with Limax flavus lectin (LFL) leads to
ERK and MLC phosphorylation (A, B). HUVECs were treated for 15 min with the indicated concentration of LFL and then lysed. G protein a12/13
mediates influenza-induced ERK phosphorylation. (C) HUVECs were tranfected with the indicated siRNA; 24 h later the cells were infected with
influenza virus (MOI, 10) and then collected after 8 h. The pictures are representative of 4 independent experiments.
doi:10.1371/journal.pone.0021444.g005
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MLC phosphorylation are well documented [4]. However, the
role of HRas\Raf\MEK\ERK activation in MLC phosphoryla-
tion has not been fully studied. Thus, we overexpressed the CA
mutant of HRas, RhoA, and PKC-a in HUVECs to determine
their effect on ERK and MLC phosphorylation. The activation of
HRas, RhoA, and PKC-a led to phosphorylation of ERK and
MLC (Fig. 7 E, F). HRas-induced phosphorylation of MLC was
attenuated when ERK phosphorylation was inhibited with DN
ERK (Fig. 7 E), indicating a critical role for ERK in HRas-
induced MLC phosphorylation. These experiments suggest that
HRas\Raf\MEK\ERK, PKC-a, and RhoA are critical for
influenza-induced ERK and MLC phosphorylation.
MLC phosphorylation is critical for nuclear export of
influenza ribonucleoprotein
Replication and transcription of the influenza virus genome
occurs exclusively within the nucleus of the infected cells. The viral
RNA genome, polymerase subunits, and nucleoprotein form
ribonucleoprotein (RNP) complexes, which are then exported
from the nucleus to form budding virions at the cell membrane.
This process requires viral activation of the cellular Raf/MEK/
ERK signaling cascade. Accordingly, blocking this signaling
pathway inhibits the export of RNP complexes and reduces titers
of progeny virus [12]. To determine which part of the viral
replication cycle requires MLC phosphorylation, we examined the
intracellular trafficking of the influenza virus in HUVECs.
Immunofluorescence studies showed that inhibiting ERK with
DN ERK blocked the nuclear export of influenza RNP complexes
(Fig. 8 A, two top rows). Similarly, inhibiting MLC phosphory-
lation by blocking RhoA or MLC kinase restricted the nuclear
translocation of RNP complexes (Fig. 8 B, C).
The contractile function of the actin cytoskeleton depends on
MLC phosphorylation and the presence of actin filaments.
Impeding actin polymerization inhibits the internalization of
influenza virus [18]. To determine the role of the actin
cytoskeleton in the nuclear export of influenza RNP complexes,
we inhibited actin polymerization with the use of cytochalasin D.
Figure 6. Inhibition or induction of MLC phosphorylation inhibits or enhances influenza proliferation, respectively. Inhibition of MLCK
leads to inhibition of influenza replication. MDCK cells were treated with serial dilutions of the MLC kinase inhibitor ML7 for 16 h (A) or were transfected
with a DN mutant of MLCK for 24 h (B). The cells were infected with influenza virus (MOI, 0.01), and virus yield was measured 24 h later by RT-PCR.
Inhibitors of Rho kinase and phospholipase C inhibitors inhibit influenza proliferation. MDCK cells were treated with the indicated concentrationso f
Fasudil(C)orthephospholipaseCinhibitor, U73122(D)and16 hlaterwereinfectedwithinfluenzavirus(MOI, 0.01). TreatmentofHUVECswithPMAand
TNF-aleads tophosphorylationofMLC. (E) HUVECs treatedfor15 minwith5 nMPMAor 20 ng/mlTNF-a.TreatmentofHUVECswith PMA,calyculinA or
TNF-a enhances influenza proliferation. (F–H) HUVECs were treated with the indicated concentrations of PMA (F), calyculin A (G) or TNF-a (H) for
30 minutes and then infected with influenza (MOI, 0.01). After 24 h, virus yield was measured by RT-PCR. Influenza-induced MLC phosphorylation is
inhibited by inhibitors of MEK/ERK, Raf kinase and phospholipase C. (I) HUVECs were pretreated with PD98059(5 Mm, 2 h), GW 5074 or U73112 (10 mM
each for 2 h), infected with 10 MOI of influenza virus, and collected 8 h later. *P,0.01; N=4 for each experiments.
doi:10.1371/journal.pone.0021444.g006
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dose-dependent restriction in influenza virus proliferation.
Inhibitor/chemical Signaling cascade/effect Concentrations Pretreatment (h)
1 C3 exoenzyme Rho A GTPase/inhibitor 0–20 mg/ml 2
2 U0126 Mek1/2/inhibitor 0–20 mM2
3 PD98059 Mek/ERK/inhibitor 0–5 mM8
4 Bisindolylmaleimide I Protein kinase C/inhibitor 0–10 mM2
5 GW 5074 Raf-1/inhibitor 0–10 mM2
6 Trifluoperazin dimaleate Calmodulin/antagonist 0–20 mM8
7 BAPTA-AM Intracellular calcium/chelator 0–5 mM 0.5
8 Verapamil Calcium channel/blocker 0–50 mM8
9 Sodium nitroprusside Nitric oxide/donor 0–100 mM2
10 8-Br-cGMP Protein kinase G/activator 0–100 mM2
11 Cytochalasin D Actin polymerization/inhibitor 0–30 mM 0.5
MDCK cells were treated with the solvent used for dissolving the chemicals, DMSO or PBS (control) or serial dilutions of the indicated chemicals for the indicated time.
The cells were infected with influenza A virus (MOI, 0.01) and 24 h after the infection, RT-PCR was used to measure the virus yield in the medium. The proliferation of
influenza virus was inhibited in a dose-dependent manner for all chemicals (graphs not shown). N=4 for each experiment.
doi:10.1371/journal.pone.0021444.t001
Figure 7. HRas activation increases phosphorylation of MLC. Influenza-induced MLC phosphorylation is inhibited by inhibiting HRas, RhoA,
and PKC. (A, B) HUVECs were transduced with the indicated adenoviruses and infected 48 h later with influenza virus (MOI 10). The cells were
collected 8 h later for blotting. Limax flavus lectin (LFL)–induced MLC and ERK phosphorylation depends on HRas, Raf-1, PKC-a, and RhoA. (C, D)
HUVECs were transduced with the indicated adenoviruses; 48 h later, the cells were treated for 15 min with LFL [100 mg/ml]. Activation of HRas,
RhoA, and PKC-a leads to MLC and ERK phosphorylation. (E, F) Western blots performed 48 hours after HUVECs were transduced with empty
adenovirus vector (Null) or the indicated adenoviruses. *P,0.01; N=4 for each experiment.
doi:10.1371/journal.pone.0021444.g007
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infection with influenza delayed the nuclear translocation of RNP
complexes (Fig. 8 D), indicating the importance of the actin
cytoskeleton in this process. In MDCK cells, nuclear export of
influenza RNP complexes was also inhibited by blocking Rho A
and MLC kinase (data not shown).
MLC phosphorylation mediates the role of HRas/Raf/
MEK/ERK in influenza proliferation
Wesought to determine if MLC phosphorylation mediates the role
of HRas\Raf\MEK\ERK in influenza proliferation. The reduction
in influenza proliferation seen when MDCK cells were treated with
the MEK/ERK inhibitor, U0126, or with the Raf kinase inhibitor,
GW5074, was reversed when MDCK cells were also treated with the
MLCphosphataseinhibitor,calyculinA(Fig.9A).InductionofERK
phosphorylation by overexpression of the CA-HRas enhanced
influenza proliferation (Fig. 9 B). This effect was reversed when
MDCK cells were cotransduced with DN mutants of MLC kinase,
ERK,orRaf-1(Fig.9B),suggestingthattheeffectofHRasactivation
oninfluenza virus proliferationis mediatedby MLC phosphorylation.
In addition, an increase in MLC phosphorylation by treatment of
HUVECs with calyculin A or siRNA against MLC phosphatase
reversed the inhibitory effect of DN ERK on the nuclear
translocation of influenza RNP complexes (Fig. 8 A).
To assess the possible clinical applications of our findings in
HUVECs and MDCK cells, we conducted experiments using the
NHBE cells because lung epithelial cells are the primary target cell
ofinfluenza.InNHBEcells,knocking downRhokinasewith siRNA
inhibited the nuclear translocation of influenza RNP complexes
(Fig. 9 C), as observed in HUVECs and MDCK cells. Furthermore,
influenza infection activated the same signal transduction pathways
in NHBE cells as in HUVECs and MDCK cells (data not shown).
Discussion
In the present study, we have shown that influenza infection
activates the signaling pathways that converge to induce MLC
phosphorylation and actin cytoskeleton remodeling. Inhibiting
Figure 8. Inhibition of ERK and MLC phosphorylation and actin polymerization leads to nuclear retention of influenza RNP
complexes. The effect of ERK on the nuclear export of influenza RNP complexes is mediated by MLC phosphorylation. (A) HUVECs cells were
cultured on chamber slides, transduced with the indicated adenovirus, and, 24 laters, transfected with the indicated siRNA. After 24 h, the cells were
infected with influenza virus (MOI 10). Calyculin A (0.5 nM) was added to the indicated sample 30 minutes before the infecton. Eight h later, the cells
were stained for the presence of influenza nucleoprotein (NP) protein (green). Inhibition of RhoA leads to inhibition of the nuclear export of influenza
RNP complexes. (B, C) HUVECs were transduced with the indicated adenoviruses (B) and constructs (C) and were processed as described above.
Polymerized actin is necessary for the nuclear export of influenza RNP complexes. (D) MDCK cells were infected with influenza virus (MOI 10) and
treated 2 h later with DMSO or 30 mM of cytochalasin D. After 6 h, the cells were fixed and stained. Hoechst 33342 was used as nuclear counterstain
(blue). Bar, 5 mm; N=4 for each experiment.
doi:10.1371/journal.pone.0021444.g008
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action for a significant group of anti-influenza agents. In
particular, we showed that MEK/ERK inhibitors suppressed the
proliferation of influenza virus by blocking MLC phosphorylation.
In addition, inhibition of MLC phosphorylation led to the nuclear
retention of viral RNP complexes in late stages of the viral
replication cycle, thus reducing proliferation of the influenza virus.
To our knowledge, we are the first to report the influenza-
induced activation of RhoA/Rho kinase and MLC phosphoryla-
tion. In addition, we observed that RhoA activation leads to ERK
phosphorylation. RhoA had been shown to prevent apoptosis in
zebrafish by activating ERK cascade [45]. On the other hand,
RhoA has been found to bind and activate the kinase activity of
MEKK1 in HEK 293 cells [44]. Scaffold protein MEKK1 is known
to phosphorylate MEK1 via its kinase activity and to recruit Ras,
Raf1 and MEK1 leading to the promotion of ERK activation
[43,44]. The accumulation of influenza hemagglutinin in the late
stages of the viral replication cycle has been shown to lead to
phosphorylation of ERK [32]. Using a different approach, we
showed that sialic acid, the cell receptor of influenza hemagglutinin,
bound to a specific lectin reproduces influenza-induced phosphor-
ylation of ERK and MLC. In support of our findings, previous
studies have shown that the interaction of influenza hemagglutinin
with sialic acid initiates activation of PKC [10]. Although lectins
have a defined specificity for their carbohydrate substrate and are
thus deemed highly specific, lectin binding can also be considered
nonspecific because numerous proteins may be glycosylated in an
identical fashion. Therefore,althoughchemical specificityis integral
to lectin chemistry, the biology is not as restricted as that seen in
antibody reactions [46]. Therefore, the results should be interpreted
with careful consideration. Our finding that HRas plays a critical
role upstream of RAF/MEK/ERK differs from the results of the
study by Marjuki and colleagues who reported a prominent role for
PKC-a [32]. To study influenza replication in MDCK cells, they
used DN mutants of PKC-a and Ras to inhibit their functions. After
6 hours, a greater reduction in viral titer was reported with DN
PKC-a than with DN RAS, although the latter was still associated
with a 60% reduction in viral titer. For DN Ras this effect did not
remain significant after 8 hours. However, in the present study, we
showed that activation ofHRas, PKC-a, and RhoA arerequired for
influenza-induced ERK phosphorylation. This discrepancy in
results may be explained by the methodology used to inhibit HRas;
Marjuki and colleagues used a plasmid vector to inhibit HRas,
whereas we used an adenovirus, which more efficiently inhibits
HRas. The molecular pathways that link hemagglutinin/sialic acid
interaction to activation of HRas\Raf\MEK\ERK, PKC-a,
RhoA, and Rho kinase pathways are not known. Our studies
indicate that inhibition of HRas\Raf\MEK\ERK, PKC-a,o r
Figure 9. Induction of MLC phosphorylation reverses the inhibitory effects of HRas\ERK on influenza proliferation. The anti-influenza
effects of Raf kinase and MEK/ERK inhibitors were reversed when HUVECs were treated with an MLC phosphatase inhibitor. (A) MDCK cells were
treated as indicated GW5074 and U0126 at 10 mM each overnight; calyculin A at 0.5 mM for 1 h] and then infected with influenza (MOI, 0.01). After
24 h, virus yield was measured in the medium by using RT-PCR. HRas-enhanced influenza proliferation is attenuated by inhibition of MLC kinase, ERK
and Raf-1. (B) MDCK cells were seeded on 24-well plates, transduced with the indicated adenovirus, and transfected 24 h later with the indicated
constructs. The cells were infected with influenza A virus (MOI, 0.01) and 24 h after the infection, RT-PCR was used to measure the virus yield in the
medium. Inhibition of Rho kinase 1 in human bronchial epithelial cells leads to inhibition of the nuclear translocation of influenza RNP complexes. (C)
Human bronchial epithelial cells were seeded on chamber slides, transfected with the indicated siRNA, and infected 24 h later with influenza virus
(MOI, 10). After 8 h, the cells were stained for influenza nucleoprotein (NP) protein. Hoechst 33342 was used as a nuclear counterstain (blue). Bar,
5 mm; *P,0.01; N=4 for each experiment.
doi:10.1371/journal.pone.0021444.g009
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ylation. In addition, inhibition of MLC phosphorylation by
inhibiting any of these pathways leads to restriction in influenza
virus replication. This finding suggests that activation of each of
these pathways is critical for influenza virus proliferation. Further
studies are needed to reveal the molecular mechanisms underlying
this phenomenon. We speculate that simultaneous activaton of
MLC kinase and inactivation of MLC phosphatase is critical for
influenza-induced MLC phosphorylation.Therefore, inhibition of
MLC kinase or activation of MLC phosphatase by inhibition of any
of HRas\Raf\MEK\ERK, PKC-a and RhoA signal transductions
leads to suppression of influenza-induced MLC phosphorylation.
The other possible scenario is that influenza virus uses the
crossroads between these pathways to activate HRas\Raf\ME-
K\ERK, PKC-a and RhoA signal transductions simultaneously.
Therefore, inhibition of any of these pathways leads to inhibition of
the others and attenuation of influenza-induced MLC phosphor-
ylation. Because of how these pathways intersect, several molecular
models can be proposed for their activation by influenza. For
example, our results suggest that of the heterotrimeric G proteins,
Ga12/13 is critical for influenza-induced ERK activation. Activa-
ton of Ga12/13 leads to RhoA and phospholipase C-e activation
[34,47]. Phospholipase C-e is known to activate Ras and PKC
[48,49]. Besides, some activation mechanisms of RhoA by Ras had
been reported [50,51].
We found that MLC phosphorylation is critical for the export of
influenza RNP complexes from the nucleus. However, it is not clear
how MLC phosphorylation contributes to the nuclear translocation
of influenza RNP complexes. Many bacterial and viral pathogens
facilitate infection by inducing actin polymerization in the cytoplasm
ofhostcells.The actincytoskeleton playsacritical roleinendocytosis
and in intracellular trafficking of viruses [52,53]. Actin is a highly
conserved protein and is one of the main components of the
cytoplasm and nucleus in eukaryotic cells. In the nucleus, actin is
involved in several processes, including transcription and transcrip-
tion regulation, RNA processing and export, intranuclear move-
ment, and maintenance of nuclear structure [54,55]. Early studies
indicated that actin or actin-like structures were involved in
intranuclear transport and nuclear export of viruses [56,57]. It has
been suggested that viral capsids use myosin-based–directed
transport to travel along nuclear actin filaments [58]. In addition,
increasing evidence suggests that the cytoplasmic and nuclear pools
of actin are functionally linked. The signaling pathways for both
pools are similar. The nucleus contains several signaling molecules,
including phosphoinositides, Ca
2+, and small GTPases, all of which
have well-characterized effects on actin dynamics in the cytoplasm
[59]. Therefore, it is tempting to speculate that phosphorylation of
MLC and actin remodeling in the cytoplasm leads to corresponding
changes in the nucleus, facilitating the nuclear transport of influenza
either by alteration in gene expression or through an actin-
dependent intranuclear transport system.
In conclusion, our studies indicate that phosphorylation of MLC
is critical for the proliferation of influenza virus, and inhibition of
MLC phosphorylation is the mechanism underlying the effects of
many anti-influenza agents.
Acknowledgments
We thank Rebecca Bartow, PhD, of the Texas Heart Institute at St. Luke’s
Episcopal Hospital for editorial assistance.
Author Contributions
Conceived and designed the experiments: MH. Performed the experi-
ments: WZ ZC LG MA. Analyzed the data: MH. Wrote the paper: MH.
References
1. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI (2006) Adamantane resistance
among influenza A viruses isolated early during the 2005–2006 influenza season
in the United States. Jama 295: 891–894.
2. Radtke K, Dohner K, Sodeik B (2006) Viral interactions with the cytoskeleton: a
hitchhiker’s guide to the cell. Cell Microbiol 8: 387–400.
3. Lincoln TM (2007) Myosin phosphatase regulatory pathways: different functions
or redundant functions? Circ Res 100: 10–12.
4. Hirano K (2007) Current topics in the regulatory mechanism underlying the
Ca2+ sensitization of the contractile apparatus in vascular smooth muscle.
J Pharmacol Sci 104: 109–115.
5. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, et al. (1996) Regulation of
myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science
273: 245–248.
6. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, et al. (1997)
Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:
481–492.
7. Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, et al. (1999)
Myosin light chain kinase functions downstream of Ras/ERK to promote
migration of urokinase-type plasminogen activator-stimulated cells in an
integrin-selective manner. J Cell Biol 146: 149–164.
8. Xiao D, Longo LD, Zhang L (2005) Alpha1-adrenoceptor-mediated phosphor-
ylation of MYPT-1 and CPI-17 in the uterine artery: role of ERK/PKC.
Am J Physiol Heart Circ Physiol 288: H2828–2835.
9. Bolz SS, Vogel L, Sollinger D, Derwand R, de Wit C, et al. (2003) Nitric oxide-
induced decrease in calcium sensitivity of resistance arteries is attributable to
activation of the myosin light chain phosphatase and antagonized by the RhoA/
Rho kinase pathway. Circulation 107: 3081–3087.
10. Arora DJ, Gasse N (1998) Influenza virus hemagglutinin stimulates the protein kinase
C activity of human polymorphonuclear leucocytes. Arch Virol 143: 2029–2037.
11. Hartshorn KL, Collamer M, White MR, Schwartz JH, Tauber AI (1990)
Characterization of influenza A virus activation of the human neutrophil. Blood
75: 218–226.
12. Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, et al. (2001) Influenza
virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling
cascade. Nat Cell Biol 3: 301–305.
13. Hartshorn KL, Daigneault DE, White MR, Tuvin M, Tauber JL, et al. (1992)
Comparison of influenza A virus and formyl-methionyl-leucyl-phenylalanine
activation of the human neutrophil. Blood 79: 1049–1057.
14. Root CN, Wills EG, McNair LL, Whittaker GR (2000) Entry of influenza
viruses into cells is inhibited by a highly specific protein kinase C inhibitor. J Gen
Virol 81: 2697–2705.
15. Nugent KM, Shanley JD (1984) Verapamil inhibits influenza A virus replication.
Arch Virol 81: 163–170.
16. Ochiai H, Kurokawa M, Niwayama S (1991) Influence of trifluoperazine on the
late stage of influenza virus infection in MDCK cells. Antiviral Res 15: 149–160.
17. Rimmelzwaan GF, Baars MM, de Lijster P, Fouchier RA, Osterhaus AD (1999)
Inhibition of influenza virus replication by nitric oxide. J Virol 73: 8880–8883.
18. Sun X, Whittaker GR (2007) Role of the actin cytoskeleton during influenza
virus internalization into polarized epithelial cells. Cell Microbiol 9: 1672–1682.
19. Haidari M, Ali M, Ward Casscells S, III, Madjid M (2009) Pomegranate (Punica
granatum) purified polyphenol extract inhibits influenza virus and has a
synergistic effect with oseltamivir. Phytomedicine 16: 1127–1136.
20. Ward CL, Dempsey MH, Ring CJ, Kempson RE, Zhang L, et al. (2004) Design
and performance testing of quantitative real time PCR assays for influenza A
and B viral load measurement. J Clin Virol 29: 179–188.
21. Woods A, Beier F (2006) RhoA/ROCK signaling regulates chondrogenesis in a
context-dependent manner. J Biol Chem 281: 13134–13140.
22. Madonna R, Di Napoli P, Massaro M, Grilli A, Felaco M, et al. (2005)
Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in
embryonic cardiac myoblasts. J Biol Chem 280: 13503–13511.
23. Ding Y, Kantarci A, Badwey JA, Hasturk H, Malabanan A, et al. (2007)
Phosphorylation of pleckstrin increases proinflammatory cytokine secretion by
mononuclear phagocytes in diabetes mellitus. J Immunol 2007 Jul 1;179(1):
647–54.
24. Novak EJ, Rabinovitch PS (1994) Improved sensitivity in flow cytometric
intracellular ionized calcium measurement using fluo-3/Fura Red fluorescence
ratios. Cytometry 17: 135–141.
25. June CH, Abe R, Rabinovitch PS (2001) Measurement of intracellular calcium
ions by flow cytometry. Curr Protoc Cytom Chapter 9: Unit 9 8.
26. Haidari M, Wyde PR, Litovsky S, Vela D, Ali M, et al. (2010) Influenza virus
directly infects, inflames, and resides in the arteries of atherosclerotic and normal
mice. Atherosclerosis 208: 90–96.
27. Sumikoshi M, Hashimoto K, Kawasaki Y, Sakuma H, Suzutani T, et al. (2008)
Human influenza virus infection and apoptosis induction in human vascular
endothelial cells. J Med Virol 80: 1072–1078.
28. Ludwig S (2007) Exploited defense-how influenza virus takes advantage of
antiviral signaling responses. Future Virol 2: 91–100.
Myosin Light Chain and Influenza
PLoS ONE | www.plosone.org 12 June 2011 | Volume 6 | Issue 6 | e2144429. Ludwig S, Pleschka S, Planz O, Wolff T (2006) Ringing the alarm bells:
signalling and apoptosis in influenza virus infected cells. Cell Microbiol 8:
375–386.
30. Trybus KM, Lowey S (1984) Conformational states of smooth muscle myosin.
Effects of light chain phosphorylation and ionic strength. J Biol Chem 259:
8564–8571.
31. Scholey JM, Taylor KA, Kendrick-Jones J (1980) Regulation of non-muscle
myosin assembly by calmodulin-dependent light chain kinase. Nature 287:
233–235.
32. Marjuki H, Alam MI, Ehrhardt C, Wagner R, Planz O, et al. (2006) Membrane
accumulation of influenza A virus hemagglutinin triggers nuclear export of the
viral genome via protein kinase Calpha-mediated activation of ERK signaling.
J Biol Chem 281: 16707–16715.
33. Simons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol
Cell Biol 1: 31–39.
34. Neves SR, Ram PT, Iyengar R (2002) G protein pathways. Science 296:
1636–1639.
35. Draznin MB, Rapoport RM, Murad F (1986) Myosin light chain phosphory-
lation in contraction and relaxation of intact rat thoracic aorta. Int J Biochem
18: 917–928.
36. Ihara E, Moffat L, Ostrander J, Walsh MP, MacDonald JA (2007)
Characterization of protein kinase pathways responsible for Ca2+ sensitization
in rat ileal longitudinal smooth muscle. Am J Physiol Gastrointest Liver Physiol
293: G699–710.
37. van Nieuw Amerongen GP, Draijer R, Vermeer MA, van Hinsbergh VW (1998)
Transient and prolonged increase in endothelial permeability induced by
histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res
83: 1115–1123.
38. Ludwig S, Wolff T, Ehrhardt C, Wurzer WJ, Reinhardt J, et al. (2004) MEK
inhibition impairs influenza B virus propagation without emergence of resistant
variants. FEBS Lett 561: 37–43.
39. Olschlager V, Pleschka S, Fischer T, Rziha HJ, Wurzer W, et al. (2004) Lung-
specific expression of active Raf kinase results in increased mortality of influenza
A virus-infected mice. Oncogene 23: 6639–6646.
40. English J, Pearson G, Wilsbacher J, Swantek J, Karandikar M, et al. (1999) New
insights into the control of MAP kinase pathways. Exp Cell Res 253: 255–270.
41. Yeung K, Seitz T, Li S, Janosch P, McFerran B, et al. (1999) Suppression of Raf-
1 kinase activity and MAP kinase signalling by RKIP. Nature 401: 173–177.
42. Wing MR, Bourdon DM, Harden TK (2003) PLC-epsilon: a shared effector
protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling. Mol Interv
3: 273–280.
43. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP (2007) Scaffold
proteins of MAP-kinase modules. Oncogene 26: 3185–3202.
44. Gallagher ED, Gutowski S, Sternweis PC, Cobb MH (2004) RhoA binds to the
amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 279:
1872–1877.
45. Zhu S, Korzh V, Gong Z, Low BC (2008) RhoA prevents apoptosis during
zebrafish embryogenesis through activation of Mek/Erk pathway. Oncogene 27:
1580–1589.
46. Sharon N, Lis H (1989) Lectins as cell recognition molecules. Science 246:
227–234.
47. Hains MD, Wing MR, Maddileti S, Siderovski DP, Harden TK (2006)
Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by
lysophosphatidic acid and thrombin receptors. Mol Pharmacol 69: 2068–2075.
48. Ikuta S, Edamatsu H, Li M, Hu L, Kataoka T (2008) Crucial role of
phospholipase C epsilon in skin inflammation induced by tumor-promoting
phorbol ester. Cancer Res 68: 64–72.
49. Seifert JP, Zhou Y, Hicks SN, Sondek J, Harden TK (2008) Dual activation of
phospholipase C-epsilon by Rho and Ras GTPases. J Biol Chem 283:
29690–29698.
50. Chen JC, Zhuang S, Nguyen TH, Boss GR, Pilz RB (2003) Oncogenic Ras leads
to Rho activation by activating the mitogen-activated protein kinase pathway
and decreasing Rho-GTPase-activating protein activity. J Biol Chem 278:
2807–2818.
51. Xia M, Land H (2007) Tumor suppressor p53 restricts Ras stimulation of RhoA
and cancer cell motility. Nat Struct Mol Biol 14: 215–223.
52. Mercer J, Helenius A (2009) Virus entry by macropinocytosis. Nat Cell Biol 11:
510–520.
53. Ohkawa T, Volkman LE, Welch MD () Actin-based motility drives baculovirus
transit to the nucleus and cell surface. J Cell Biol 190: 187–195.
54. Castano E, Philimonenko VV, Kahle M, Fukalova J, Kalendova A, et al. (2010)
Actin complexes in the cell nucleus: new stones in an old field. Histochem Cell
Biol 133: 607–626.
55. Hofmann WA (2009) Cell and molecular biology of nuclear actin. Int Rev Cell
Mol Biol 273: 219–263.
56. Forest T, Barnard S, Baines JD (2005) Active intranuclear movement of
herpesvirus capsids. Nat Cell Biol 7: 429–431.
57. Hofmann W, Reichart B, Ewald A, Muller E, Schmitt I, et al. (2001) Cofactor
requirements for nuclear export of Rev response element (RRE)- and
constitutive transport element (CTE)-containing retroviral RNAs. An unexpect-
ed role for actin. J Cell Biol 152: 895–910.
58. Feierbach B, Piccinotti S, Bisher M, Denk W, Enquist LW (2006) Alpha-
herpesvirus infection induces the formation of nuclear actin filaments. PLoS
Pathog 2: e85.
59. Vartiainen MK (2008) Nuclear actin dynamics–from form to function. FEBS
Lett 582: 2033–2040.
Myosin Light Chain and Influenza
PLoS ONE | www.plosone.org 13 June 2011 | Volume 6 | Issue 6 | e21444